Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000709702 | SCV001146724 | likely pathogenic | Phenylketonuria | 2019-07-07 | reviewed by expert panel | curation | The c.3G>C (p.Met1Ile) variant in PAH is a null variant (start loss) where LOF is a known mechanism of disease. There are no known alternative start codons in other transcripts. The next in-frame Met is at amino acid 180 in exon 6. There are 49 pathogenic variants in ClinVar upstream of aa 180. The p.Met1Val variant has <3% enzyme activity as compared to wild type (PMID: 9450897), confirming start loss variants lead to loss of function of the PAH enzyme without re-initiation. This variant is absent in population databases (PM2). This variant has not been reported in an affected individual in the literature to our knowledge. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PVS1. |
Labcorp Genetics |
RCV000709702 | SCV004540586 | pathogenic | Phenylketonuria | 2023-09-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 585206). Disruption of the initiator codon has been observed in individual(s) with hyperphenylalaninemia (PMID: 2574002, 10679941, 24941924, 30159852). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the PAH mRNA. The next in-frame methionine is located at codon 180. |
Clinical Laboratory, |
RCV000709702 | SCV000839873 | pathogenic | Phenylketonuria | 2018-06-26 | no assertion criteria provided | case-control |